0001140361-17-033117.txt : 20170823 0001140361-17-033117.hdr.sgml : 20170823 20170823172043 ACCESSION NUMBER: 0001140361-17-033117 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170821 FILED AS OF DATE: 20170823 DATE AS OF CHANGE: 20170823 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KAPLAN ANDREW J CENTRAL INDEX KEY: 0001582246 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33675 FILM NUMBER: 171047738 MAIL ADDRESS: STREET 1: SUITE 200 623 RIVER ROAD CITY: FAIR HAVEN STATE: NJ ZIP: 07704 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bioptix, Inc. CENTRAL INDEX KEY: 0001167419 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 841553387 STATE OF INCORPORATION: CO FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 834-F SOUTH PERRY STREET, SUITE 443 CITY: CASTLE ROCK STATE: CO ZIP: 80104 BUSINESS PHONE: 303-794-2000 MAIL ADDRESS: STREET 1: 834-F SOUTH PERRY STREET, SUITE 443 CITY: CASTLE ROCK STATE: CO ZIP: 80104 FORMER COMPANY: FORMER CONFORMED NAME: Venaxis, Inc. DATE OF NAME CHANGE: 20121218 FORMER COMPANY: FORMER CONFORMED NAME: AspenBio Pharma, Inc. DATE OF NAME CHANGE: 20051110 FORMER COMPANY: FORMER CONFORMED NAME: ASPENBIO INC DATE OF NAME CHANGE: 20020213 4 1 doc1.xml FORM 4 X0306 4 2017-08-21 0 0001167419 Bioptix, Inc. BIOP 0001582246 KAPLAN ANDREW J C/O BIOPTIX, INC. 834-F SOUTH PERRY STREET, SUITE 443 CASTLE ROCK CO 80104 1 0 0 0 Common Stock 2017-08-21 4 A 0 10000 0.00 A 2916 D Represents a restricted stock award under the Bioptix, Inc. Amended & Restated Equity Incentive Plan (the "Restricted Stock Award"), which shall vest in 24 equal monthly installments over a two year period, beginning on the one month anniversary of the date of issuance. The vesting of the Restricted Stock Award is subject to acceleration upon the occurrence of a "Qualifying Transaction", as such term is defined in the Restricted Stock Award. Restricted Stock Award is compensation for the Reporting Person's service on the Board. Represents shares vested or to be vested within 60 days pursuant to restricted stock awards. /s/ Andrew Kaplan 2017-08-23